BRPI0509533A - compostos de agentes antivirais, composição farmacêutica e seus usos - Google Patents

compostos de agentes antivirais, composição farmacêutica e seus usos

Info

Publication number
BRPI0509533A
BRPI0509533A BRPI0509533-6A BRPI0509533A BRPI0509533A BR PI0509533 A BRPI0509533 A BR PI0509533A BR PI0509533 A BRPI0509533 A BR PI0509533A BR PI0509533 A BRPI0509533 A BR PI0509533A
Authority
BR
Brazil
Prior art keywords
compounds
pharmaceutical composition
formula
antiviral agents
addition
Prior art date
Application number
BRPI0509533-6A
Other languages
English (en)
Inventor
Jonathan Alan Victor Coates
Eric Dale Jones
Susan Cox
Ian Crosby
David Gerard Bourke
Tyrone Pieter Jeynes
Original Assignee
Univ Monash
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2004901755A external-priority patent/AU2004901755A0/en
Application filed by Univ Monash filed Critical Univ Monash
Publication of BRPI0509533A publication Critical patent/BRPI0509533A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPOSTOS DE AGENTES ANTIVIRAIS, COMPOSIçãO FARMACêUTICA E SEUS USOS A presente invenção fornece um método de tratamento ou profilaxia do vírus da hepatite B em uma pessoa, compreendendo a administração de uma quantidade eficaz de um composto de fórmula (1) ou de um derivado, sal ou pró-medicamento farmaceuticamente aceitável desse. Além disso, são fornecidos compostos de fórmula (1) e composições farmacêuticas desses. Ademais, são revelados métodos de preparação de compostos de fórmula (1).
BRPI0509533-6A 2004-03-31 2005-03-31 compostos de agentes antivirais, composição farmacêutica e seus usos BRPI0509533A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2004901755A AU2004901755A0 (en) 2004-03-31 Antiviral agents
PCT/AU2005/000453 WO2005095376A1 (en) 2004-03-31 2005-03-31 Antiviral agents

Publications (1)

Publication Number Publication Date
BRPI0509533A true BRPI0509533A (pt) 2007-09-18

Family

ID=35063698

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0509533-6A BRPI0509533A (pt) 2004-03-31 2005-03-31 compostos de agentes antivirais, composição farmacêutica e seus usos

Country Status (9)

Country Link
EP (1) EP1737836A1 (pt)
JP (1) JP2007530600A (pt)
KR (1) KR20070009655A (pt)
CN (1) CN101018775A (pt)
BR (1) BRPI0509533A (pt)
CA (1) CA2561896A1 (pt)
MX (1) MXPA06011205A (pt)
WO (1) WO2005095376A1 (pt)
ZA (1) ZA200608992B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010251272A1 (en) * 2009-05-20 2011-12-15 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
CN106866609B (zh) * 2017-02-08 2018-11-16 江西本草天工科技有限责任公司 小花清风藤中一种新化合物的制备方法及应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995029920A1 (en) * 1994-04-29 1995-11-09 The University Of North Carolina At Chapel Hill Khellactone derivatives and related compounds, process for their preparation and their use as antiviral and immunostimulating agents

Also Published As

Publication number Publication date
KR20070009655A (ko) 2007-01-18
ZA200608992B (en) 2008-05-28
MXPA06011205A (es) 2007-07-19
JP2007530600A (ja) 2007-11-01
WO2005095376A1 (en) 2005-10-13
CA2561896A1 (en) 2005-10-13
EP1737836A1 (en) 2007-01-03
CN101018775A (zh) 2007-08-15

Similar Documents

Publication Publication Date Title
RS114004A (en) Modified 2' and 3'-nucleoside produgs for treating flaviridae infections
DE60228857D1 (de) Amino-phtalazinon derivate, anwendung als kinase inhibitoren, herstellung und pharmazeutische zusammensetzung
NO20060974L (no) Pyridazinderivater og deres anvendelse som terapeutiske midler
NO20060981L (no) Pyridazinderivater og deres anvendelse som terapeutiske midler
WO2008100447A3 (en) Nucleoside analogs for antiviral treatment
MXPA04012965A (es) Inhibidores virales.
WO2001072721A3 (en) Synergistic methods and compositions for treating cancer
MXPA04005156A (es) Antagonistas del receptor de adenosina a2a.
UA94901C2 (ru) Антибактериальные производные пиперидина
MEP26208A (en) 4`-supstituted nucleosides
MX2007004183A (es) Derivados de benzoimidazol utiles como agentes antiproliferacion.
RS20050522A (en) Protein kinase inhibiting tricyclic compounds that increase the effects of anti-neoplastic agents and therapeutic radiation
MXPA01006474A (es) Derivados colquinol como agentes perjudiciales vasculares.
NO20072689L (no) Tetrasykliske indolderivater som antivirale midler
NO20073357L (no) 5-karboksamid substituerte tiazol derivater som reagerer med ionekanaler, i saerdeleshet med ionekanaler fra Kv familien
NO20052130L (no) Sterk inhibitor for HCV-serin-protease
WO2006086447A3 (en) Pyridazine derivatives and their use as therapeutic agents
HK1062677A1 (en) 17Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
BR0210122A (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo
WO2007046868A3 (en) Thiazolidine derivatives and their uses as therapeutic agents
BRPI0415953A (pt) formulação de dosagem de liberação controlada oral, método de tratamento de um distúrbio, conjunto de formas de dosagem de liberação controlada e método para administração da formulação
MX2008008556A (es) Derivados de triterpenoquinonas y triterpenofenoles y su aplicacion para el tratamiento de tumores y enfermedades parasitarias.
WO2007064448A3 (en) Cancer treatment using fts and 2-deoxyglucose
ATE372995T1 (de) Benzo(b)(1,4)dioxepinderivate
WO2006125194A3 (en) Piperazine derivatives and their uses as therapeutic agents

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.